92618 ⎘
Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
POLYMORPHIC FORMS OF (R)-OXYBUTYNIN HYDROCHLORIDE
#2NANOMATERIALS
#3INTERMEDIATE OF POLYAMINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
#4POLYMORPHIC FORMS OF (R)-OXYBUTYNIN HYDROCHLORIDE
#5NOVEL COMPOUND USEFUL AS TOLL-LIKE RECEPTOR 7 ACTIVATION INHIBITOR
#6PROCESS FOR PREPARATION OF FINGOLIMOD HYDROCHLORIDE
#7Biological buffers with wide buffering ranges
#8NANOMATERIALS
#9Biological buffers with wide buffering ranges
#10Biological buffers with wide buffering ranges
#11Lipids and lipid compositions for the delivery of active agents
#12Biological Buffers with Wide Buffering Ranges
#13Biological Buffers with Wide Buffering Ranges
#14Biological buffers with wide buffering ranges
#15Reference markers for fesoterodine fumarate
#16NOVEL REFERENCE MARKERS FOR FESOTERODINE FUMARATE
#17Amine derivative compounds for treating ophthalmic diseases and disorders
#18Lipids and lipid compositions for the delivery of active agents
#19Inhibiting neurotransmitter reuptake
#20Process for reduction of alpha-acyloxy sulfide derivatives
#21Amine derivative compounds for treating ophthalmic diseases and disorders
#22Amine derivative compounds for treating ophthalmic diseases and disorders
#23Prodrugs of oxazolidinone CETP inhibitors
#24SALTS OF TRIMEBUTINE AND N-DESMETHYL TRIMEBUTINE
#25Inhibiting neurotransmitter reuptake
#26Acylation reaction of hydroxyl group
#27Process for the preparation of optically pure R (−) salbutamol and its pharmaceutically acceptable salts
#28Aminoalcohol Derivatives and Their Therapeutic Use
#29Anesthetic Compounds
#30Preparation of 3-[(1,2)-3-(dimethylamino)-1ethyl-2-methylpropyl]phenol
#31Amine derivative compounds for treating ophthalmic diseases and disorders
#322-amino-2-phenyl-alkanol derivatives, their preparation and pharmaceutical compositions containing them
#33Pharmaceutical compounds
#34Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
#35Salts of trimebutine and N-desmethyl trimebutine
#36Pharmaceutical compounds
#37UII-modulating compounds and their use
#38Nitroderivatives of cardiovascular agents
#39Narcotic-NSAID ion pairs
#40Compounds and methods